List of Studies ( Metabolite:Sedoheptulose 1,7-bisphosphate)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST002970 | AN004879 | Untargeted metabolomics of fatty alcohol production at time 90 min of bioconversion | Bacterial cells | Bacteria | Vidyasirimedhi Institute of Science and Technology | abundance | |
ST002759 | AN004480 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Kidney cortex | Rat | Medical College of Wisconsin | Area | |
ST002760 | AN004484 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) | Kidney outer medulla | Rat | Medical College of Wisconsin | Area | |
ST002245 | AN003665 | Deciphering the metabolomic differences between two fast-growing cyanobacteria, S.elongatus PCC 11801 and 11802 via metabolite profiling | Bacterial cells | Synechococcus elongatus | Indian Institute of Technology Bombay | Area Ratios | |
ST001850 | AN002997 | Unbiased LC-MS-based metabolomics analysis for both whole cell and mitochondria metabolites to gain an insight into the role of Tug1/PGC1 axis on metabolite profiles in podocytes | Epithelial cells | Mouse | University of Texas MD Anderson Cancer Center | AUC/ngDNA | |
ST002119 | AN003468 | Metabolomics analysis of zebrafish response to CID661578 treatment | Larvae | Zebrafish | Diabetes | North Carolina State University | ion counts |
ST001660 | AN002711 | Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors | Cultured cells | Fungi | Malaria | Pennsylvania State University | Normalized and blank subtracted peak area |
ST001660 | AN002711 | Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | Normalized and blank subtracted peak area |
ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Blood | Human | Malaria | Pennsylvania State University | Peak Abundance (normalized, blank subtracted, and corrected for baseline noise) |
ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | Peak Abundance (normalized, blank subtracted, and corrected for baseline noise) |
ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Cultured cells | Human | Malaria | Pennsylvania State University | Peak Abundance (normalized, blank subtracted, and corrected for baseline noise) |
ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | Peak Abundance (normalized, blank subtracted, and corrected for baseline noise) |
ST002024 | AN003294 | Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | Peak Abundance (normalized, blank subtracted, and corrected for baseline noise) |
ST002011 | AN003277 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | peak area |
ST002011 | AN003278 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | peak area |
ST002011 | AN003279 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | peak area |
ST002078 | AN003387 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | peak area |
ST002078 | AN003388 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | peak area |
ST002078 | AN003389 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | peak area |
ST002078 | AN003390 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | peak area |
ST002371 | AN003866 | High-resolution metabolomics analysis of NLRP3 inflammasome activated macrophages | Macrophages | Mouse | Inflammation | Wake Forest School of Medicine | peak area |
ST000116 | AN000197 | Comparative metabolomics analysis of the key metabolic nodes in propionic acid synthesis in Propionibacterium acidipropionici | Bacterial cells | Propionibacterium | Jiangnan University | Peak area | |
ST000142 | AN000225 | H1299 13C-labeled Cell Study | Lung | Human | Cancer | University of Kentucky | Peak area |
ST001611 | AN002646 | Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment | Muscle | Mouse | Cancer | North Carolina State University | Peak area |
ST001611 | AN002646 | Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment | Sarcoma | Mouse | Cancer | North Carolina State University | Peak area |
ST001149 | AN001896 | Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | Peak Area Post-Blank Subtraction |
ST001180 | AN001958 | Metabolome Profiling of Synechococcus elogatus PCC 11802 | Cultured cells | Synechococcus elongatus | Indian Institute of Technology, Bombay | Peak area ratio | |
ST001298 | AN002162 | Metabolome Profiling of Synechococcus elongatus PCC 11801 strains engineered for Succinate Production | Bacterial cells | Synechococcus elongatus | Indian Institute of Technology Bombay (IIT Bombay) | Peak area ratio | |
ST001302 | AN002168 | Metabolome Profiling of a Fast-growing Cyanobacterium Synechococcus elongatus PCC 11801 under Diurnal Cycle | Bacterial cells | Synechococcus | Indian Institute of Technology Bombay | Peak area ratio | |
ST002115 | AN003513 | LC-MS analysis of metabolic changes induced by GPX4 inhibitor treatment in cultured HT1080 cells | Cultured cells | Human | University of Texas MD Anderson Cancer Center | Peak area (top) | |
ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | Peak height |
ST003112 | AN005111 | Glucose Hypometabolism Prompts RAN Translation and Exacerbates C9orf72-related ALS/FTD Phenotypes | Brain | Mouse | Neurodegenerative Disorder | Thomas Jefferson University | peak intensity |
ST003113 | AN005098 | Inhibition of Asparagine Synthetase Effectively Retards Polycystic Kidney Disease Progression, investigated with targeted tracing metabolomics analysis in MEF cells using 15N2-glutamine. | Cultured cells | Mouse | Kidney disease | San Raffaele University | peak intensity |
ST003113 | AN005099 | Inhibition of Asparagine Synthetase Effectively Retards Polycystic Kidney Disease Progression, investigated with targeted tracing metabolomics analysis in MEF cells using 15N2-glutamine. | Cultured cells | Mouse | Kidney disease | San Raffaele University | peak intensity |
ST003118 | AN005112 | Glucose Hypometabolism Prompts RAN Translation and Exacerbates C9orf72-related ALS/FTD Phenotypes - Study 2 | Brain | Mouse | Neurodegenerative Disorder | Thomas Jefferson University | peak intensity |
ST001201 | AN001999 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001201 | AN001999 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001202 | AN002001 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001202 | AN002001 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001205 | AN002007 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001205 | AN002007 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001549 | AN002581 | β-Adrenergic regulation of metabolism in macrophages (part-III) | Macrophages | Human | Monash University | Peak intensity | |
ST002541 | AN004187 | Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids (Part 1) | Yeast cells | Yeast | Life Sciences Institute, ZheJiang University | Peak intensity | |
ST002542 | AN004189 | Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids (Part 2) | Yeast cells | Yeast | Life Sciences Institute, ZheJiang University | Peak intensity | |
ST002281 | AN003726 | Metabolite patterns between isogenic normal hiPSCs and Trisomy hiPSC | iPSC cells | Human | Down syndrome | Guangdong provincial people's hospital | pmoles/l |
ST002805 | AN004561 | IL-1β-mediated adaptive re-programming of endogenous human cardiac fibroblasts to cells with immune features during fibrotic remodeling | Cultured cells | Human | Pulmonary hypertension | Brown University | Q3 Peak Area (area under curve) |
ST002108 | AN003449 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) | Blood | Plasmodium falciparum | Malaria | Monash University | relative intensity |
ST001377 | AN002297 | Stirred suspension bioreactors maintain naïve pluripotency of human pluripotent stem cells (hPSCs) | Stem cells | Human | University of Calgary | relative signal intensity compared to media only |